Genentech Inc. Newsletter
-
Ventus Therapeutics enters agreement with Genentech to discover and develop small-molecule medicines using Ventus’ ReSOLVE platform
23 Oct 2025 04:48 GMT
… multi-year collaboration with Genentech, a member of the … scientific officer of Ventus. “Genentech is a world leader in … against multiple targets, and Genentech will conduct subsequent preclinical … other discovery programs at Genentech. Ventus will receive an …
-
<![CDATA[Genentech’s Phase III MEERKAT and SANDCAT Trials Show Vision and Anatomical Gains With Vamikibart in Uveitic Macular Edema]]>
23 Oct 2025 01:30 GMT
… 33 treated patients.
References
1. Genentech Presents New Phase III Pivotal … of Vision Loss. News release. Genentech. October 17, 2025. Accessed October … /2025-10-17/genentech-presents-new-phase-iii-pivotal …
-
Ventus and Genentech collaborate on drug discovery
22 Oct 2025 15:31 GMT
… a multi-year collaboration with Genentech Inc., a member of the …
-
Ventus and Genentech partner for small-molecule medicine discovery
22 Oct 2025 12:39 GMT
… partnership with Roche’s Genentech for the discovery and … the medicinal chemistry strategy for Genentech’s active programmes.
Discover … range of targets, with Genentech taking on the subsequent … and accelerating patient benefit.
“Genentech is a world leader …
-
Genentech wins approval of lupus drug obinutuzumab
20 Oct 2025 23:16 GMT
The US FDA approved Gazyva (obinutuzumab), a lupus nephritis treatment from Roche-owned (OTCQX:RHHBY) Genentech. Gazyva is given via infusion four times in the first year, followed by twice a year after that. In a phase 3 study, 46.4% of patients on Gazyva
-
Genentech’s Phase III evERA data showed giredestrant improved PFS survival
19 Oct 2025 23:57 GMT
Genentech, a member of the Roche ( …
-
TBWA\NZ boosts strategic and client service with four new hires
23 Oct 2025 06:44 GMT
… and campaign strategy for Blackstone, Genentech and Volkswagen. She brings strategic …
-
Federal Circuit Draws Tight Boundaries Around Functional Claiming
23 Oct 2025 00:56 GMT
… filters. Citing the decision in Genentech, Inc. v. Novo Nordisk A …
-
OHSU Study: Dangerous Bacteria Stops Gut’s Infection Defense Mechanism
23 Oct 2025 00:29 GMT
… recently in Nature, scientists from Genentech in collaboration with researchers from …
-
Machine model may predict MS recurrence risk after DMT discontinuation
22 Oct 2025 20:43 GMT
… NIH; receiving funding from Biogen, Genentech and Novartis; receiving consulting fees … from EMD Serono and Genentech.
Add topic to email alerts …
About
© 1995-2025